Atlas Trials

Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency

Clinical trial NCT04020328 · UNKNOWN

Trial details

NCT number
NCT04020328
Sponsor
Shenzhen Second People's Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Glomerulonephritis, IGARenal Insufficiency, Chronic
Start date
2019-09-12
Primary completion
2022-03-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.